COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2)
T. Ratneswaren, N. Chan, J. Aeron-Thomas, S. Sait, O. Adesalu, M. Alhawamdeh, M. Benger, J. Garnham, L. Dixon, F. Tona, C. Mcnamara, E. Taylor, K. Lobotesis, E. Lim, O. Goldberg, N. Asmar, O. Evbuomwan, S. Banerjee, L. Holm-Mercer, J. SenorY. Tsitsiou, P. Tantrige, A. Taha, K. Ballal, A. Mattar, A. Daadipour, K. Elfergani, R. Barker, R. Chakravartty, A.g. Murchison, B.j. Kemp, R. Simister, I. Davagnanam, O.y. Wong, D. Werring, A. Banaras, M. Anjari, J.k.c. Mak, A.m. Falzon, J.c.l. Rodrigues, C.a.s. Thompson, I.r. Haines, T.a. Burnett, R.e.y. Zaher, V.l. Reay, M. Banerjee, C.s.l. Sew hee, A.p. Oo, A. Lo, P. Rogers, T. Hughes, A. Marin, S. Mukherjee, H. Jaber, E. Sanders, S. Owen, M. Bhandari, S. Sundayi, A. Bhagat, M. Elsakka, O.h. Hashmi, M. Lymbouris, Y. Gurung-Koney, M. Arshad, I. Hasan, N. Singh, V. Patel, M. Rahiminejad, T.C. Booth
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'COVID-19 Stroke Apical Lung Examination Study 2: a national prospective CTA biomarker study of the lung apices, in patients presenting with suspected acute stroke (COVID SALES 2)'. Together they form a unique fingerprint.